• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 5MAX REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 5MAX REPERFUSION CATHETER; NRY Back to Search Results
Catalog Number PSC054
Device Problem Insufficient Information (3190)
Patient Problems Intimal Dissection (1333); Intracranial Hemorrhage (1891); Reocclusion (1985)
Event Date 08/30/2013
Event Type  Injury  
Event Description
The patient was undergoing a thrombectomy procedure in the right middle cerebral artery (mca - m1) using a penumbra system 5max reperfusion catheter and a 5max separator.Before the procedure, intravenous tissue plasminogen (iv t-pa) was not administered.During the procedure, a 5max reperfusion catheter was advanced to the target vessel along with another manufacturer's guide wire and guiding catheter.Aspiration was done with a 5max separator and recanalization was successful; however, occlusion reoccurred.The patient was given 500 units of heparin by injection.A percutaneous transluminal angioplasty was performed and 120,000 units of uk were injected into the selective artery.The second recanalization was successful; however, re-occlusion occurred again.While attempting to stent the patient, the patient developed intracranial hemorrhage caused by dissection.Craniotomy for removal of thrombus and angiography was performed and the patient recovered.Physician comments: re-occlusions possibly resulted from damage on the wall of the mca, which caused by the 5max.It could not be denied that the event was related to the penumbra system and the procedure.
 
Manufacturer Narrative
Conclusion: dissection/hemorrhage is a known and anticipated complication with these types of procedures and are noted in the device labeling.Therefore, it was determined that the reported event was an anticipated procedural complication.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.This mdr is associated with mdr 3005168196-2014-00400.Device was disposed of by the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 5MAX REPERFUSION CATHETER
Type of Device
NRY
Manufacturer (Section D)
PENUMBRA, INC.
1351 harbor bay parkway
alameda CA 94502
Manufacturer (Section G)
PENUMBRA, INC.
1351 harbor bay parkway
alameda CA 94502
Manufacturer Contact
kathleen kidd
1351 harbor bay parkway
alameda, CA 94502
5107483200
MDR Report Key3885096
MDR Text Key4676238
Report Number3005168196-2014-00399
Device Sequence Number1
Product Code NRY
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K090752
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 05/20/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/19/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date04/30/2016
Device Catalogue NumberPSC054
Device Lot NumberF34680
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/20/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/18/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
Patient Weight50
-
-